Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 20 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Holders of 5% or more of PHVS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pharvaris N.V., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| General Atlantic LLC | 13G/A | 7.60%5.36M shares | – | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Viking Global Investors LPSuperinvestorViking Global Investors | 13G/A | 5.60%3.65M shares | – | May 15, 20261 filing | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Pharvaris N.V., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20268:52 PM ET | General Atlantic LLCand 14 others | 13G/A | 7.60%5.36M shares | – | Jun 30, 2026 | SEC |
| Jul 31, 20267:22 AM ET | LSP V Cooperatieve U.A.and 1 other | 13G/A | 4.90%3.42M shares | –Below 5% | Jun 30, 2026 | SEC |
| May 15, 20265:48 PM ET | Viking Global Investors LPand 6 othersSuperinvestorViking Global Investors | 13G/A | 5.60%3.65M shares | – | Mar 31, 2026 | SEC |
| Feb 17, 20264:30 PM ET | Bain Capital Life Sciences Fund, L.P.and 2 others | 13G/A | 2.50%1.64M shares | −0.50 ppfrom 3.00%Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 20254:30 PM ET | Bain Capital Life Sciences Fund, L.P.and 2 others | 13G/A | 3.00%1.87M shares | –Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20255:56 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 3.80%2.05M shares | –Below 5% | Jun 30, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Pharvaris N.V. shares.
No Form 144 notices for Pharvaris N.V. are on file.